Sclerosing skin disorders in association with multiple sclerosis. Coincidence, underlying autoimmune pathology or interferon induced?

Annals of the Rheumatic Diseases

Volumn 68, Issue 1, 2009, Pages 47-50

  Hugle T ^a   Gratzl, S ^a   Daikeler, T ^a   Frey, D ^a   Tyndall, A ^a   Walker, U A ^a,b  

^a UNIVERSITY OF BASEL   (Switzerland)

^b Felix Platter Spital ^*  (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; ANTINUCLEAR ANTIBODY; BETA INTERFERON; CORTICOSTEROID;

ADULT; AGED; ANTISYNTHETASE SYNDROME; ARTHRALGIA; ARTICLE; AUTOIMMUNE DISEASE; CASE REPORT; CLINICAL ARTICLE; DIGITAL ULCER; DISEASE ACTIVITY; EDEMA; FEMALE; HUMAN; HYPERPIGMENTATION; MALE; MULTIPLE SCLEROSIS; MYALGIA; PRIORITY JOURNAL; RAYNAUD PHENOMENON; SCLERODERMA; STOMACH CARCINOMA; SYSTEMIC SCLEROSIS; ULCER;

ADJUVANTS, IMMUNOLOGIC; AGED; FEMALE; HUMANS; INTERFERON-BETA; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS, RELAPSING-REMITTING; RAYNAUD DISEASE; SCLERODERMA, DIFFUSE; TIME FACTORS;

EID: 58349097708     PISSN: 00034967     EISSN: 14682060     Source Type: Journal    
DOI: 10.1136/ard.2007.083246     Document Type: Article

References (23)

1. Ramagopalan SV, Dyment DA, Valdar W, Herrera BM, Criscuoli M, Yee IM, et al. Autoimmune disease in families with multiple sclerosis: a population-based study. Lancet Neurol 2007; 6:604-10.
2. Borg FA, Isenberg DA. Syndromes and complications of interferon therapy. Curr Opin Rheumatol 2007; 19:61-6.
3. Pelidou SH, Tsifetaki N, Giannopoulos S, Deretzi G, Voulgari P, Kyritsis A. Multiple sclerosis associated with systemic sclerosis. Rheumatol lot 2007; 27:771-3.
4. Broadley SA, Deans J, Sawcer SJ, Clayton D, Compston DA. Autoimmune disease in first-degree relatives of patients with multiple sclerosis. A UK survey. Brain 2000; 123(Pt 6):1102-11.
5. Caramaschi P, Biasi D, Volpe A, Carletto A, Cecchetto M, Bambara LM. Coexistence of systemic sclerosis with other autoimmune diseases. Rheumatol Int 2007; 27:407-10.
6. Walker UA, Tyndall A, Czirjak L, Denton C, Farge-Bancel D, Kowal-Bielecka O. et al. Clinical risk assessment of organ manifestations in systemic sclerosis: a report from the EULAR Scleroderma Trials And Research group database. Ann Rheum Dis 2007; 66:754-63.
7. Do HT, Baars W, Borns K, Windhagen A, Schwinzer R. The 77C->G mutation in the human CD45 (PTPRC) gene leads to increased intensity of TCR signaling in T cell lines from healthy individuals and patients with multiple sclerosis. J Immunol 2006; 176:931-8.
8. Tourbah A, Clapin A, Gout O, Fontaine B, Liblau R, Batteux F, et al. Systemic autoimmune features and multiple sclerosis: a 5-year follow-up study. Arch Neurol 1998; 55:517-21.
9. Niewold TB, Swedler Wl. Systemic lupus erythematosus arising during interferonalpha therapy for cryoglobulinemic vasculitis associated with hepatitis C. Clin Rheumatol 2005; 24:178-81.
10. Crispin JC, Diaz-Jouanen E. Systemic lupus erythematosus induced by therapy with interferon-beta in a patient with multiple sclerosis. Lupus 2005; 14:495-6.
11. Black CM, Silman AJ, Herrick Al. Denton CP, Wilson H, Newman J, et al. Interferonalpha does not improve outcome at one year in patients with diffuse cutaneous scleroderma: results of a randomized, double-blind, placebo-controlled trial. Arthritis Rheum 1999; 42:299-305.
12. Needleman BW, Wigley FM, Stair RW. lnterleukin-1, interleukin-2, interleukin-4, interleukin-6, tumor necrosis factor alpha, and interferon-gamma levels in sera from patients with scleroderma. Arthritis Rheum 1992; 35:67-72.
13. Ochi H, Feng-Jun M, Osoegawa M, Minohara M, Murai H, Taniwaki T, et al. Timedependent cytokine deviation toward the Th2 side in Japanese multiple sclerosis patients with interferon beta-1b. J Neurol Sci 2004; 222:65-73.
14. Hogaboam CM, Steinhauser ML, Chensue SW, Kunkel SL Novel roles for chemokines and fibroblasts in interstitial fibrosis. Kidney Int 1998; 54:2152-9.
15. Solans R, Bosch JA, Esteban I, Vilardell M. Systemic sclerosis developing in association with the use of interferon alpha therapy for chronic viral hepatitis, Clin Exp Rheumatol 2004; 22:625-8.
16. Igarashi A, Imakado S, Ishibashi Y, Takehara K. Systemic sclerosis associated with multiple sclerosis. Arch Dermatol 1989; 125:1145.
17. Gorodkin R, Leahy B, Neary D, Herrick AL. Coexistence of systemic sclerosis and multiple sclerosis. J Neurol 2004; 251:1524-5.
18. Jawad SH, Askari A, Ward AB. Case history of a patient with multiple sclerosis and scleroderma. Br J Rheumatol 1997; 36:502-3.
19. Trostle DC, Helfrich D, Medsger TA Jr. Systemic sclerosis (scleroderma) and multiple sclerosis. Arthritis Rheum 1986; 29:124-7.
20. Spadaro A, Sensi F, Barrella M, Francia A. Systemic sclerosis and multiple sclerosis. J Neurol 1999; 246:497-9.
21. Chroni E, Paschalis C, Stergiou T, Vlahanastasi C, Andonopoulos AP. Multiple sclerosis in the course of systemic sclerosis. Ann Rheum Dis 2002: 61:188.
22. Tahara H, Kojima A, Hirokawa T, Oyama T, Naganuma A, Maruta S, et al. Systemic sclerosis after interferon alphacon-1 therapy for hepatitis C. Intern Med 2007; 46:473-6.
23. Beretta L, Caronni M, Vanoli M, Scorza R. Systemic sclerosis after interferon-alfa therapy for myeloproliferative disorders. Br J Dermatol 2002; 147:385-6.